AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 112 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $65,000 | -12.2% | 139,317 | +6.6% | 0.01% | -11.1% |
| Q4 2021 | $74,000 | -64.4% | 130,716 | +3.9% | 0.01% | -67.9% |
| Q3 2021 | $208,000 | +34.2% | 125,844 | +31.7% | 0.03% | +27.3% |
| Q2 2021 | $155,000 | +50.5% | 95,542 | +55.5% | 0.02% | +29.4% |
| Q1 2021 | $103,000 | -41.8% | 61,433 | -45.0% | 0.02% | -45.2% |
| Q4 2020 | $177,000 | +84.4% | 111,788 | -6.2% | 0.03% | +40.9% |
| Q3 2020 | $96,000 | +35.2% | 119,217 | +6.2% | 0.02% | +29.4% |
| Q2 2020 | $71,000 | +77.5% | 112,215 | +14.4% | 0.02% | +21.4% |
| Q1 2020 | $40,000 | -24.5% | 98,056 | +7.5% | 0.01% | 0.0% |
| Q4 2019 | $53,000 | +96.3% | 91,251 | +67.3% | 0.01% | +75.0% |
| Q3 2019 | $27,000 | +35.0% | 54,558 | +12.3% | 0.01% | +14.3% |
| Q2 2019 | $20,000 | -13.0% | 48,562 | +14.2% | 0.01% | -12.5% |
| Q1 2019 | $23,000 | +43.8% | 42,511 | +25.8% | 0.01% | +14.3% |
| Q4 2018 | $16,000 | +60.0% | 33,800 | +70.8% | 0.01% | +133.3% |
| Q3 2018 | $10,000 | -66.7% | 19,787 | +32.0% | 0.00% | -72.7% |
| Q2 2018 | $30,000 | -38.8% | 14,993 | +3.3% | 0.01% | -45.0% |
| Q1 2018 | $49,000 | – | 14,515 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |